(Los Angeles, CA) — The HIV gene medicines company Calimmune announced today that the first patient has begun treatment in a Phase I/II clinical trial designed to determine whether a pioneering genetic medicine approach can help to protect individuals infected with HIV from the effects of the virus. The study, “Safety Study of a Dual …
Calimmune Initiates HIV Stem Cell Study at Two California Research Sites Read More »
SANGAMO BIOSCIENCES PRESENTS CLINICAL DATA DEMONSTRATING HIV RESERVOIR REDUCTION IN HIV-INFECTED SUBJECTS TREATED WITH ZFP THERAPEUTIC®, SB-728-T Unprecedented Immune Reconstitution Drives HIV Viral Reservoir DepletionEncouraging Preliminary Anti-Viral HIV Data during Treatment Interruption in Ongoing SB-728-T Phase 2 Trials Richmond, California, May 15, 2013 – Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of new …
Timothy Brown made medical history when he became the first patient who was essentially cured of HIV, after receiving a stem cell transplant from a person who was genetically resistant to the infection. Now, doctors are hoping to build on Brown’s success by treating HIV patients using cord blood units that have the same HIV-resistant …
Doctors turn to cord blood transplants in hopes of curing patients with HIV Read More »
Great overview written in layman’s terms Controversies in HIV cure research Journal of the International AIDS Society 2012, 15:16 doi:10.1186/1758-2652-15-1 Rowena Johnston (rowena.johnston@amfar.org) Francoise Barre-Sinoussi (fbarre@pasteur.fr) …
